ReleaseWire Connect

Oral cancer is one of the largest group of cancers, which comes under category of Head and Neck cancer. It includes lips, tongue, throat, sinuses, and floor of the mouth. About 90% of the oral cancers are squamous cell carcinoma (OSCC). According to oral cancer foundation in 2016, around 48,250 people are diagnosed with oral cancer in the U.S. and has relatively low survival rates. The death rates due to oral cancer are relatively higher due to lack of proper diagnosis test, which can detect oral cancer at the early stage. Hence, early stage diagnosis is an alternative solution that helps prevent the deaths of people infected by oral cancer.

Transparency Market Research has published a new report on the global fundus cameras market. According to the report, the global fundus cameras market is expected to expand at a 4.50% CAGR during the period between 2013 and 2019.

In a new study, Transparency Market Research (TMR) has identified Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, Johnson and Johnson, Bristol Myers Squibb Company, Novartis Ag, and Allergen Plc as some of the most prominent enterprises operating in the global antibacterial drugs market.

This 72-page research publication, titled "Facial Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020", states that developing at a steady CAGR of 14.60% from 2014 to 2020, the global facial injectables market is projected to grow from a value of US$3.3 bn in 2013 to US$9.4 bn by 2020.

Transparency Market Research (TMR) has recently published a research study on the global surgical navigation systems market, estimating it to expand at a CAGR of 4.50% during the period from 2014 to 2020 and reach a market value of 295.5 mn by the end of the forecast period.

TMR's report, titled 'Endoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019', studies the global endoscopy devices market based on the device type, areas of application, and geography. According to the report, the market was valued at US$24.9 billion in 2012 and is further expected to reach an approximate value of US$36.9 billion in 2019. The overall market is growing at a CAGR of 6.8% from 2013 to 2019. In the past few years, the demand for endoscopy devices has increased tremendously due to the growing preference for minimally invasive surgeries and demand for cost-effective endoscopic procedures in terms of pre- and post-surgical operations.

Pancreatic cancer is caused by the unrestrained growth of cells in the pancreas. This abnormal, uncontrolled growth of cells leads to the formation of lumps of tissue, commonly referred to as tumors. The presence of tumors hinders the normal functioning of pancreas.

There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of these life saving drugs. However, these possibilities are opposed by some scientific challenges and unanswered questions.

The Latin America home healthcare market is exhibiting a CAGR of 8.7% from 2014 to 2020. The market was valued at US$9.8 bn in 2013 and is expected to be valued at US$17.5 bn in 2020. The statistical data has been compiled in a research report released by Transparency Market Research, titled "Latin America Home Healthcare Market (By Device Types: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies; By Services: Rehabilitation, Telehealth and Telemedicine, Respiratory Therapy, Infusion Therapy and Unskilled Home Healthcare Services) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020".

Out of the drug class segments, bisphosphonates were the fastest growing segment and held 48.2% of the overall osteoporosis drugs market in 2013. However, analysts predict that pipeline drugs will showcase accelerated growth at a CAGR of 125.20% from 2014 to 2020.The International Osteoporosis Foundation (IOF) stated that at least 9 mn fractures and bone cracks occur every year. In addition to this, about 200 mn women across the world are expected to be victims of osteoporosis with each passing year. With these alarming figures, growth of the global osteoporosis drug is only expected to accelerate. In addition, introduction of new drug classes that hold the promise of overcoming the threat of chronic and generics side effects of the established drugs is yet another factor making a positive influence on the growth of the global osteoporosis drugs market.